Vericel (VCEL) Total Debt Growth (1y) (2011 - 2018)
Vericel (VCEL) Total Debt Growth (1y) (2011 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Vericel |
2.04 Bn |
1.90 Bn |
49.27 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2018 |
52.07% |
| Jun 30, 2018 |
109.29% |
| Mar 31, 2018 |
70.33% |
| Dec 31, 2017 |
2,107.40% |
| Sep 30, 2017 |
1,138.43% |
| Jun 30, 2017 |
15,763.46% |
| Mar 31, 2017 |
16,230.65% |
| Dec 31, 2016 |
1,042.25% |
| Sep 30, 2016 |
764.20% |
| Jun 30, 2016 |
-42.86% |
| Mar 31, 2016 |
-38.00% |
| Dec 31, 2015 |
-84.46% |
| Sep 30, 2015 |
-47.06% |
| Jun 30, 2015 |
-96.36% |
| Mar 31, 2015 |
4,900.00% |
| Dec 31, 2014 |
7,516.67% |
| Sep 30, 2014 |
1,430.00% |
| Jun 30, 2014 |
13,057.89% |
| Mar 31, 2014 |
-93.10% |
| Dec 31, 2013 |
-85.00% |
